Neoneurogenesis and the neuro-neoplastic synapse

Progress in Experimental Tumor Research

Volumn 39, Issue , 2007, Pages 91-98

  Palm, Daniel ^a   Entschladen, Frank ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CHEMOKINE; NERVE GROWTH FACTOR;

ANIMAL; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; REVIEW; SYNAPSE; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CHEMOKINES; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; PERIPHERAL NERVOUS SYSTEM; SYNAPSES;

EID: 33847380198     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000100049     Document Type: Review

References (37)

1. Chedotal A, Kerjan G, Moreau-Fauvarque C: The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 2005;12:1044-1056.
2. Folkman J, Merler E, Abernathy C, Williams G: Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-288.
3. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
4. Carmeliet P: VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69(suppl 3):4-10.
5. Strieter RM: Masters of angiogenesis. Nat Med 2005;11:925-927.
6. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP: CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005;16:593-609.
7. Jeong BS, Choi NS, Ahn SK, Bae H, Kim HS, Kim D: Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol. Bioorg Med Chem Lett 2005;15:3580-3583.
8. McColl BK, Stacker SA, Achen MG: Molecular regulation of the VEGF family - inducers of angiogenesis and lymphangiogenesis. APMIS 2004;112:463-480.
9. Thiele W, Sleeman JP: Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol 2006;124:224-241.
10. Orellana C: Is lymphangiogenesis as important as angiogenesis? Lancet Oncol 2005;6:265.
11. Schoppmann SF: Lymphangiogenesis, inflammation and metastasis. Anticancer Res 2005;25:4503-4511.
12. Massi D, Puig S, Franchi A, Malvehy J, Vidal-Sicart S, Gonzalez-Cao M, Baroni G, Ketabchi S, Palou J, Santucci M: Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 2006;59:166-173.
13. McColl BK, Loughran SJ, Davydova N, Stacker SA, Achen MG: Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancer. Curr Cancer Drug Targets 2005;5:561-571.
14. Cao Y: Tumor angiogenesis and therapy. Biomed Pharmacother 2005;59(suppl 2):S340-S343.
15. Geldof AA, Van Haarst EP, Newling DW: Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis 1998;1:236-241.
16. Dolle L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H: Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 2003;22:5592-5601.
17. Schneider MB, Standop J, Ulrich A, Wittel U, Friess H, Andren-Sandberg A, Pour PM: Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer. J Histochem Cytochem 2001;49:1205-1210.
18. Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, Cavazzana A, Cardillo G, Amenta F, Bisetti A, Barbolini G: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 2001;25:439-446.
19. Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand G, Thompson EW: Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 1993;53:1416-1420.
20. Dolle JP, Rezvan A, Allen FD, Lazarovici P, Lelkes PI: Nerve growth factor-induced migration of endothelial cells. J Pharmacol Exp Ther 2005;315:1220-1227.
21. Wang WY, Dong JH, Liu X, Wang Y, Ying GX, Ni ZM, Zhou CF: Vascular endothelial growth factor and its receptor Flk-1 are expressed in the hippocampus following entorhinal deafferentation. Neuroscience 2005;134:1167-1178.
22. Le Bras B, Barallobre MJ, Homman-Ludiye J, Ny A, Wyns S, Tammela T, Haiko P, Karkkainen MJ, Yuan L, Muriel MP, Chatzopoulou E, Breant C, Zalc B, Carmeliet P, Alitalo K, Eichmann A, Thomas JL: VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci 2006;9:340-348.
23. Zhang H, Vutskits L, Pepper MS, Kiss JZ: VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. J Cell Biol 2003;163:1375-1384.
24. Yasuhara T, Shingo T, Date I: The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci 2004;15:293-307.
25. Potiron V, Roche J: Class 3 semaphorin signaling: the end of a dogma. Sci STKE 2005;2005:pe24.
26. Castro-Rivera E, Ran S, Thorpe P, Minna JD: Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 2004;101:11432-11437.
27. Heffner KL, Loving TJ, Robles TF, Kiecolt-Glaser JK: Examining psychosocial factors related to cancer incidence and progression: In search of the silver lining. Brain Behav Immun 2003;17:109-111.
28. Algazi M, Plu-Bureau G, Flahault A, Dondon MG, Le MG: Could treatments with beta-blockers be associated with a reduction in cancer risk? Rev Epidemiol Sante Publique 2004;52:53-65.
29. Perron L, Bairati I, Harel F, Meyer F: Antihypertensive drug use and the risk of prostate cancer. Cancer Causes Control 2004;15:535-541.
30. Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M: Stress of daily activities and risk of breast cancer: a prospective cohort study in Finland. Int J Cancer 2001;91:888-893.
31. Lillberg K, Verkasalo PK, Kaprio J, Helenius H, Koskenvuo M: Personality characteristics and the risk of breast cancer: a prospective cohort study. Int J Cancer 2002;100:361-366.
32. Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M: Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol 2003;157:415-423.
33. Helgesson O, Cabrera C, Lapidus L, Bengtsson C, Lissner L: Self-reported stress levels predict subsequent breast cancer in a cohort of Swedish women. Eur J Cancer Prev 2003;12:377-381.
34. Ferin M: Clinical review 105: stress and the reproductive cycle. J Clin Endocrinol Metab 1999;84:1768-1774.
35. Lang K, Drell TL, Zaenker KS, Entschladen F: Inhibitors for metastasis development. Rec Pat Anti-Cancer Drug Disc 2006;1:69-80.
36. Nielsen NR, Zhang ZF, Kristensen TS, Netterstrom B, Schnohr P, Gronbaek M: Self reported stress and risk of breast cancer: prospective cohort study. BMJ 2005;331:548.
37. Reiche EM, Morimoto HK, Nunes SM: Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 2005;17:515-527.